Source: Virtual Congress 2021 – Bronchiectasis and pleural infection



Rating:

Share or cite this content

Citations should be made in the following way:
L. Bueno Freire (Barcelona, Spain), V. Alcaraz Serrano (Barcelona, Spain), L. Fernández Barat (Barcelona, Spain), G. Scioscia (Foggia, Italy), P. Oscanoa (Barcelona, Spain), N. Vázquez (Barcelona, Spain), A. López Gavin (Barcelona, Spain), A. Gabarrús (Barcelona, Spain), R. Amaro (Barcelona, Spain), A. Ceccato (Barcelona, Spain), R. López Aladid (Barcelona, Spain), A. Torres (Barcelona, Spain). Assessment of health-related quality of life in patients with bronchiectasis colonized by Pseudomonas aeruginosa. 2017

Member's Comments

No comment yet.

Related content which might interest you: Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 A single isolation of pseudomonas aeruginosa predicts poor quality of life and increased exacerbation frequency in adult bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Assessment of quality of life in patients with bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 Year: 2018 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Effects of prophylactic clarithromycin administration on quality of life in non-CF bronchiectasis patients Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Adherence in bronchiectasis (BQ) and concordance between multidimensional scales in a cohort of patients colonized by Pseudomonas aeruginosa (PsA). Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Determinants of health-related quality of life in patients with severe COPD Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011 Pseudomonas aeruginosa colonisation in patients without bronchiectasis Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Prognosis of health-related quality of life in COPD patients and its determinants Source: Eur Respir J 2001; 18: Suppl. 33, 55s Year: 2001 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 A meta-analysis of health related quality of life (HRQOL) in non-cystic fibrosis bronchiectasis (NCFB): Association with clinical outcomes Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Health-related quality of life in non-cystic fibrosis bronchiectasis children Source: Annual Congress 2011 - Rare lung diseases in children Year: 2011 Using SF-36 in assessment of quality of life in patients cured of pulmonary tuberculosis Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021 Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006 Health-related quality of life of patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 16s Year: 2004 The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018 Factors associated with quality of life measured by EQ-5D in Korean COPD patients Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013